Table: Hisamitsu -Q1 group results
Jul 8 (Reuters)-
Hisamitsu Pharmaceutical Co Inc
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
3 months ended 3 months ended Year to
May 31, 2016 May 31, 2015 Feb 28, 2017
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 38.15 39.68 155.00
(-3.8 pct) (+5.1 pct) (-4.2 pct)
Operating 5.74 5.74 28.00
(+0.1 pct) (+25.0 pct) (+1.0 pct)
Recurring 5.56 5.66 29.00
(-1.8 pct) (-14.9 pct) (+3.5 pct)
Net 4.53 3.54 19.40
(+28.1 pct) (-11.6 pct) (+9.1 pct)
EPS 53.50 yen 41.27 yen 227.79 yen
EPS Diluted 53.48 yen
Ann Div 81.00 yen 81.00 yen
-Q2 div 40.00 yen 40.50 yen
-Q4 div 41.00 yen 40.50 yen
NOTE - Hisamitsu Pharmaceutical Co Inc.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4530.T
((Tokyo Headline News Desk +813 6441 1812))
Recent news on Hisamitsu Pharmaceutical Co
See all newsTable: Hisamitsu -2025/26 group results
Table: Hisamitsu -2025/26 parent results
Brief: Hisamitsu Pharmaceutical Co Inc - To Retire Treasury Shares Worth 6.34% Of Outstanding Stock On May 12
Brief: Hisamitsu Pharmaceutical Co Inc - Tender Offer Of Company By Taiyo Kosan Successfully Completed
Japan's Hisamitsu Pharmaceutical plans $2.55 billion MBO